ReviewColchicine for the treatment of cardiovascular diseases: old drug, new targetsAndreis, Alessandro; Imazio, Massimo; De Ferrari, Gaetano MariaAuthor Information University Cardiology, AOU Città della Salute e della Scienza di Torino, Torino, Italy Correspondence to Massimo Imazio, MD, FESC, University Cardiology, AOU Città della Salute e della Scienza di Torino, Corso Bramante 88, 10126 Torino, Italy E-mail: [email protected] Received 26 May, 2020 Revised 27 June, 2020 Accepted 5 July, 2020 Journal of Cardiovascular Medicine: January 2021 - Volume 22 - Issue 1 - p 1-8 doi: 10.2459/JCM.0000000000001079 Buy Metrics Abstract Well known in past centuries as a herbal remedy for osteoarticular pain and commonly used in the treatment of gout and familial Mediterranean fever, colchicine has an emerging role in the setting of cardiovascular diseases. Its unique properties not only target the key mechanisms of recurrent inflammation underlying pericardial syndromes but also inflammation within atherosclerotic plaques, atrial fibrillation recurrence and adverse ventricular remodelling leading to heart failure. The effect of colchicine in the treatment of cardiovascular diseases along with essential pharmacology will be discussed, reviewing the most important and recent clinical studies. Colchicine is a valuable, well tolerated and inexpensive drug in the setting of cardiovascular diseases. © 2020 Italian Federation of Cardiology - I.F.C. All rights reserved.